En Es


Browse products by category

Clinical Laboratory

184 companies | 821 medical products

COVID 19 Saliva Antigen Test
COVID-19 Ag Gold

The COVID-19 Ag Gold is a rapid, reliable and easy to use COVID 19 saliva antigen test that provides results within 10 minutes. The saliva lateral flow test includes all necessary reagents and requires no additional specialist equipment to conduct a successful COVID-19 test, making it ideally suited for quick detection of the risk potential in sensitive areas of clinics, care facilities, test centers, companies, industries, and practices.
More details

COVID-19 Real Time RT-PCR Kit
respiraScreen 1

The respiraScreen 1 real time RT-PCR Kit is a screening assay for the simultaneous detection of three groups of different respiratory viruses. The design allows the differentiation of Influenza Virus (Flu A, Flu B) and Respiratory Syncytial Virus (RSV A, RSV B) from the pandemic coronavirus SARS-CoV-2, extracted from biological specimens. The kit contains specific primers and dual-labeled probes for the amplification of RNA (cDNA) of Influenza A (M gene), Influenza B (NEP gene), RSV A (G gene), RSV B (G gene) and SARS-CoV-2 (E gene) extracted from biological specimen. Furthermore, the kit contains a Control RNA (Internal Process Control, IPC), which is added during RNA extraction and detected in the same reaction by a HEX-labelled probe. The Control RNA allows the detection of RT-PCR inhibition and acts as control that the nucleic acid was isolated from the biological specimen.
More details


The COVID-19-CHECK-1 ANTIGEN is an immunochromatographic rapid test for the qualitative detection of SARS-CoV-2 virus in nasopharyngeal swab samples. The COVID-19-CHECK-1 Antigen qualitative immunochromatographic rapid test is to be used for the detection of the SARS-CoV-2 virus from nasopharyngeal swab samples by healthcare medical professionals.
More details

SARS-CoV2 Antigen Rapid Test
SARS-CoV2 Antigen Rapid Test

Monocent SARS-CoV2 Antigen Rapid test is a qualitative and immunochromatographic in vitro assay for the detection of SARS-CoV2 virus from nasal swab or nasopharyngeal swab obtained from patient with signs and symptoms of respiratory infection. It can detect the presence of SARS-CoV2 viral nucleocapsid (N) protein in nasal or nasopharyngeal specimen at very low concentration without any high dose hook effect. The CE-IVD kit includes all the necessary tools needed to run the test for 25 patients, such as cassettes, buffer, nasopharyngeal swabs, tubes with dropper caps and IFU.
More details

Nucleic Acid Extractor

The MGISP-NE32 is an automated nucleic acid extractor adopting magnetic rod technology. Together with nucleic acid extraction kit, MGISP-NE32 is able to extract and purify nucleic acid from 16/32 samples in approximately nine minutes.
More details

COVID-19 IgM/IgG Assay

The COVID-19 IgM/IgG is a chromatographic immunoassay kit for the rapid and differential detection of immunoglobulin M (IgM) and immunoglobulin G (IgG) against COVID-19 using serum, plasma and whole blood.
More details

SARS-COV-2 Variants RT- PCR Test
SARS-COV-2 Variants Real Time PCR Kit

The SARS-COV-2 Variants Real Time PCR kit uses real-time reverse transcription and amplification of nucleic acids in one step for the detection of SARS-CoV-2 and identification of the main SARS-CoV-2 variants of concern.
More details

Disposable Virus Sampling Kit
Disposable Virus Sampling Kit

Singuway’s Disposable Virus Sampling Kit is used for novel coronavirus, avian influenza (H7N9), hand foot mouth disease (HFMD), measles and other viral specimens, as well as Mycoplasma, Ureaplasma, Chlamydia and other specimens collection and transportation.
More details

SARS-CoV-2 sVNT Test

The SARS-CoV-2-NeutraLISA is a surrogate virus neutralization test (sVNT) for the semi-quantitative detection of neutralizing antibodies inhibiting the binding of SARS-CoV-2 S1/RBD to ACE2 receptors of the host cells. It supports the evaluation of the immune response after SARS-CoV-2 infection or vaccination using S1/RBD-based vaccines.
More details

COVID-19 Antigen Saliva Rapid Test
GLINE-2019-nCoV Antigen Saliva Rapid Test

The GLINE-2019-nCoV Antigen Saliva is a rapid antigen salivary test that detects nucleocapsid protein of the SARS-CoV-2 virus based on colloidal gold immunochromatography assay (CGIA). The assay is more acceptable by users and makes home-testing possible.
More details

SARS-CoV-2 Variants Assay
Allplex SARS-CoV-2 Variants I Assay

The Allplex SARS-CoV-2 Variants I Assay is intended for the detection and differentiation of three mutation sites in S gene for the identification of SARS-CoV-2 variants.
More details

GSD NovaType II SARS-CoV-2

The GSD NovaType II SARS-CoV-2 Real-Time RT-PCR assay allows for the identification of relevant mutations associated with SARS-CoV-2 variants: B.1.1.7 (UK), B.1.351 (South Africa), and B.1.1.28 (P.1) (Brazil). The assay is intended as a confirmatory test for potential mutants and should only be performed after first testing patient specimens for the presence of SARS-CoV-2 RNA with a CE-IVD marked screening assay such as the GSD NovaPrime SARS-CoV-2 (COVID-19) RT-PCR kit.
More details

SARS-CoV-2 PCR Assay
AppliedBiosystems TaqCheck SARS-CoV-2 Fast PCR Assay Kit

The AppliedBiosystems TaqCheck SARS-CoV-2 Fast PCR Assay Kit is a multiplexed, highly sensitive, fast RT‐PCR assay for the qualitative detection and characterization of SARS-CoV-2 RNA (S and N genes) that compensates for emerging variants and mutations plus a human RNAse P assay to help assess sample adequacy. The SARS-CoV-2 assays target two different viral genomic regions, reducing the risk of failure to detect SARS-CoV-2. The SARS-CoV-2 N and S gene assay targets have undergone bioinformatic selection and analysis to specifically target sequences that are unique to SARS-CoV-2. The assays are designed to work with raw saliva from research samples.
More details

SARS-CoV-2 IgG (RBD & NP) Test
SARS-CoV-2 IgG (RBD & NP) Array

The Randox SARS-CoV-2 IgG (RBD & NP) array utilizes patented biochip technology to simultaneously detect IgG antibodies against both leading COVID-19 diagnostic antigens; Spike Receptor Binding Domain (RBD) and Nucleocapsid protein (NP). Maximum sensitivity is ensured through detection of antibodies against both proteins making the assay superior compared to other commercially available serology tests where false negative results are common. Measurement of both RBD and NP IgG antibodies also provides an opportunity to discriminate vaccinated versus naturally infected individuals based on leading vaccine candidates.
More details

SARS-CoV-2 Antibody Test

The SARS-CoV-2 UTAB FS is a new particle enhanced immunoturbidimetric assay (PETIA) for the quantitative determination of total antibodies to the SARS-CoV-2 spike (S) protein receptor binding domain (RBD) in human serum. The innovative assay for reliable monitoring of antibody response following SARS-CoV-2 infection resp. COVID-19 vaccination provides a wide measuring range. As a ready-to-use assay, it features high specificity and sensitivity, shows no cross-reactivity with other highly pathogenic human coronaviruses, and is well-suited for use on almost all common clinical chemistry analyzers.
More details
Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions